4O6

(E)-2-(4-chlorophenyl)-N-{(3S)-1-[(2S)-1-(morpholin-4-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}ethenesulfonamide

Created:	2015-02-13
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where 4O6 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	2
Bond Count	55
Aromatic Bond Count	6

2D diagram of 4O6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(E)-2-(4-chlorophenyl)-N-{(3S)-1-[(2S)-1-(morpholin-4-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}ethenesulfonamide
Synonyms	GTC000406
Systematic Name (OpenEye OEToolkits)	(E)-2-(4-chlorophenyl)-N-[(3S)-1-[(2S)-1-morpholin-4-yl-1-oxidanylidene-propan-2-yl]-2-oxidanylidene-pyrrolidin-3-yl]ethenesulfonamide
Formula	C₁₉ H₂₄ Cl N₃ O₅ S
Molecular Weight	441.929
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(N1CCOCC1)C(N3C(=O)C(NS(=O)(=O)\C=C\c2ccc(Cl)cc2)CC3)C
SMILES	CACTVS	3.385	C[CH](N1CC[CH](N[S](=O)(=O)C=Cc2ccc(Cl)cc2)C1=O)C(=O)N3CCOCC3
SMILES	OpenEye OEToolkits	1.9.2	CC(C(=O)N1CCOCC1)N2CCC(C2=O)NS(=O)(=O)C=Cc3ccc(cc3)Cl
Canonical SMILES	CACTVS	3.385	C[C@H](N1CC[C@H](N[S](=O)(=O)\C=C\c2ccc(Cl)cc2)C1=O)C(=O)N3CCOCC3
Canonical SMILES	OpenEye OEToolkits	1.9.2	C[C@@H](C(=O)N1CCOCC1)N2CC[C@@H](C2=O)NS(=O)(=O)/C=C/c3ccc(cc3)Cl
InChI	InChI	1.03	InChI=1S/C19H24ClN3O5S/c1-14(18(24)22-9-11-28-12-10-22)23-8-6-17(19(23)25)21-29(26,27)13-7-15-2-4-16(20)5-3-15/h2-5,7,13-14,17,21H,6,8-12H2,1H3/b13-7+/t14-,17-/m0/s1
InChIKey	InChI	1.03	DNCVZNVETAOAJO-PPYZAHLJSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL223891
PubChem	9803364
ChEMBL	CHEMBL223891

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.